Skip to main content

Advertisement

Log in

Reforming China's drug regulatory system

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Timeline of China's drug regulatory system reform.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Liming Shao.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information

China's drug regulatory system reform timeline (May 2015 to May 2018)* (PDF 108 kb)

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, L., Gao, H., Kaitin, K. et al. Reforming China's drug regulatory system. Nat Rev Drug Discov 17, 858–859 (2018). https://doi.org/10.1038/nrd.2018.150

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2018.150

  • Springer Nature Limited

This article is cited by

Navigation